Associated Papers
Two novel mutations of SERPINB7 in eight cases of Nagashima-type palmoplantar keratosis in the Chinese population.
Xiao T et al.
The Journal of Dermatology, 2022
Acral peeling in Nagashima type palmo-plantar keratosis patients reveals the role of serine protease inhibitor B 7 in keratinocyte adhesion.
Cohen-Barak E et al.
Experimental Dermatology, 2022
Updated allele frequencies of SERPINB7 founder mutations in Asian patients with Nagashima-type palmoplantar keratosis/keratoderma.
Ito Y et al.
Journal of Dermatological Science, 2021
Nagashima-Type Palmoplantar Keratosis: Clinical Characteristics, Genetic Characterization, and Clinical Management.
Huang C et al.
Biomed Research International, 2021
33575348 (PubMed )
Supplement: 8841994.f1.zip › Supplement-Table_2__1_.docx
Novel nonsense mutation in SERPINB7 and the treatment of foot odor in a patient with Nagashima-type palmoplantar keratosis.
Katsuno M et al.
The Journal of Dermatology, 2017
Mutations in SERPINB7, encoding a member of the serine protease inhibitor superfamily, cause Nagashima-type palmoplantar keratosis.
Kubo A et al.
American Journal of Human Genetics, 2013
Nagashima-Type Palmoplantar Keratosis with Compound Heterozygous Mutations in SERPINB7.
Songsantiphap C et al.
Case Reports in Dermatology, 0
Select a paper to view details